Skip to main content

Mehta Rajat's Form 4 filing

Bio-Rad Laboratories, Inc. (BIO) · filed Sep 9, 2026

Accession no.
0002081681-26-000002
Filed
Sep 9, 2026, 6:44 PM ET
Trade date
Sep 4-5, 2026
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mehta RajatCIK 0002081681Officer (EVP, GBL Commercial Operations)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 5, 2026Bio-Rad A Common StockMOption exerciseAcquired+456$0.00$0599.052Direct
Sep 5, 2026Bio-Rad A Common StockFTax withholdingDisposed−233$386.11−$89,963.63366.052Direct
Sep 5, 2026Bio-Rad A Common StockMOption exerciseAcquired+1,370$0.00$01,736.052Direct
Sep 5, 2026Bio-Rad A Common StockFTax withholdingDisposed−504$386.11−$194,599.441,232.052Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 4, 2026Bio-Rad A Common StockAGrant or awardAcquired+4,601$0.00$04,601Direct
Sep 5, 2026Bio-Rad A Common StockMOption exerciseDisposed−456$0.00$01,371Direct
Sep 5, 2026Bio-Rad A Common StockMOption exerciseDisposed−1,370$0.00$04,110Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)